• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.13% Nasdaq Up0.70%

    United Therapeutics Corporation (UTHR)

    -NasdaqGS
    131.95 Up 1.73(1.33%) Dec 26, 4:00PM EST
    |After Hours : 131.97 Up 0.02 (0.01%) Dec 26, 4:44PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
    Total Revenue 329,951   322,802   289,403   289,017  
    Cost of Revenue40,804  38,709  30,600  38,778  
    Gross Profit 289,147   284,093   258,803   250,239  
    Operating Expenses
    Research Development118,877  39,742  12,448  121,552  
    Selling General and Administrative202,507  68,031  30,215  157,178  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (32,237) 176,320   216,140   (28,491)
    Income from Continuing Operations
    Total Other Income/Expenses Net1,113  1,459  1,686  1,423  
    Earnings Before Interest And Taxes(31,124)177,779  217,826  (27,068)
    Interest Expense4,709  4,746  4,610  4,562  
    Income Before Tax(35,833)173,033  213,216  (31,630)
    Income Tax Expense(10,596)61,181  75,692  (1,316)
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(25,237)111,852  137,524  (30,314)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (25,237) 111,852   137,524   (30,314)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (25,237) 111,852   137,524   (30,314)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.